Gender disparities in medical leadership and entrepreneurship

Medicine loves data. It also loves hierarchies. Unfortunately, those two passions don’t always agree on who gets the corner office, the department chair,
or the “sure, here’s $10 million for your startup” handshake. The result is a frustrating pattern: women are increasingly the majority in the medical
training pipeline, yet they remain underrepresented in the leadership seats that shape clinical priorities, research agendas, and innovation dollars.

This isn’t just a fairness issue (though it is that, too). Leadership decides which programs expand, which patient populations get attention, what
“counts” as high-impact work, and which problems are worthy of investment. If women are missing from those decisions, healthcare loses ideas, talent,
and credibilitylike running a hospital with one hand tied behind your back and calling it “efficient.”

The pipeline is changingso why isn’t leadership keeping up?

Women are now the majority of U.S. medical students

The most visible shift is happening where the white coats begin: women now make up a majority of U.S. medical students. In recent reporting,
women accounted for 54.6% of medical school students in the 2023–2024 academic year, after first becoming the majority in 2019–2020.
That’s not a “trend,” that’s a new normal.

But the physician workforce and leadership ladder still lag

Even as the training pipeline becomes more balanced, the active physician workforce remains more male than female. For example, women accounted for
38% of active physicians in 2022up sharply over time, but still far from parity. And the further up you climb in academic medicine,
the thinner the representation often becomes.

Consider academic leadership. In recent snapshots, women represented about 27% of U.S. medical school deans and 25%
of department chairs. The contrast is hard to ignore: when women make up the majority of learners but about a quarter of top leadership, the “pipeline”
starts looking less like a straight path and more like one of those confusing hospital hallways where every corridor says “This Way” and somehow
leads back to the cafeteria.

Even “women-heavy” departments can have “men-heavy” top roles

A particularly telling pattern shows up when you compare representation within a specialty to representation at the top. In Obstetrics and Gynecology,
for instance, women comprised about 69% of full-time faculty, yet only about 38% of department chairs. Pediatrics and
psychiatry show similar “strong presence, weaker power” dynamics in many institutions.

The takeaway is not that women “aren’t interested” in leadership. The data look more like a slow-moving escalator with a hidden speed limit: plenty of
people step on, but some groups simply move upward faster.

Why the gap persists: barriers that hide in plain sight

Promotion systems reward visibilityand visibility is not evenly distributed

Many leadership pipelines in medicine are built on “extra” roles: committee work, task forces, quality projects, teaching awards, and informal
influence. Those experiences can be career acceleratorsif they come with sponsorship, credit, and decision-making power. But they can also become
a time sink when the work is invisible, undervalued, or simply expected.

Women are often overrepresented in essential but less rewarded labor: mentoring, residency support, patient communication, and institutional “glue
work.” These tasks are important (healthcare would crumble without them), yet they may not translate into the kind of metrics that promotion committees
celebrate. In other words: you can be the person who keeps the plane in the air and still not get invited to the cockpit.

The time tax: caregiving expectations and “ideal worker” assumptions

Healthcare leadership is still frequently structured around an “ideal worker” modelsomeone available at all times, with minimal constraints outside
work. That model conflicts with the reality that women continue to carry disproportionate caregiving responsibilities in many households. In practice,
this can mean fewer high-visibility assignments, less travel, and less schedule flexibilityall of which can quietly reduce access to leadership tracks.

Importantly, flexible work is often treated like a “concession” rather than a retention strategy. When flexibility becomes synonymous with “less
committed,” it pressures clinicians to choose between sustainable careers and leadership trajectories. And medicine, which is famous for solving hard
problems, somehow struggles to solve the mystery of: “What if we designed leadership jobs for humans?”

Pay inequity signals whose work is valued

Compensation gaps don’t just affect bank accountsthey influence negotiation confidence, career mobility, and perceptions of worth. Multiple major
U.S. reports have documented persistent gender pay gaps among physicians, even after accounting for factors like specialty, location, and experience.
Some analyses estimate that women physicians earn substantially less than men on average, with gaps that can remain meaningful even when adjusting
for key variables.

In leadership terms, pay inequity can become a compounding disadvantage. Lower pay can reduce the ability to fund professional development, take
entrepreneurial risks, or “buy back” time through childcare and support systems. It’s hard to chase a leadership title when you’re also chasing a
fair paycheck.

Workplace climate and bias still shape who stays and who rises

Bias can be subtle (“she’s great, but not quite ready”) or systemic (criteria that consistently privilege certain career paths). And workplace climate
matters. National-level analyses have emphasized that harassment and gender hostility can drive attrition and derail advancement, especially in
academic environments where power imbalances are steep. You can’t build a leadership pipeline if the pipeline is leaking talent through preventable
culture problems.

Entrepreneurship: a second leadership ladder with its own glass ceiling

If medical leadership is one ladder, entrepreneurship is another. And while startups are often marketed as “meritocratic,” the funding ecosystem
frequently mirrors the same disparitiessometimes with higher stakes and fewer guardrails.

Venture capital: progress, but far from parity

In the U.S. venture market, female-founded companies have raised meaningful capital, but their share of total activity remains well below parity.
In recent PitchBook reporting, female founders collectively secured $38.8 billion in U.S. venture funding in 2024, yet their share of
overall venture activity was still around one-fifth by deal value, and roughly one-quarter by deal count.
That gap matters because deal value drives scale: who can hire faster, build faster, and dominate a market before competitors catch up.

Meanwhile, the investor side of the table remains male-dominated. Nonprofit tracking has found that women hold only about 18.6% of
Partner+ roles in venture capitalan improvement over prior years, but still a long way from representing the diversity of founders and customers in
healthcare.

Healthcare innovation has a “women+ health” paradox

Here’s the paradox: women are major healthcare decision-makers as patients, caregivers, and clinicians, and “women+ health” needs are enormous.
Yet funding hasn’t consistently matched the opportunity. In digital health, investment specifically addressing women+ health needs hit a recent high in
2024about $671 millionbut still represented only about 6.6% of all digital health funding.

That’s progress, and it’s real. But it also shows how much room remains for growth, especially when you consider how many conditions are influenced
by sex differences, reproductive life stages, and caregiving realities. Underinvestment isn’t just a market inefficiencyit can become a health
inequity amplifier.

Concrete example: women-led healthcare startups can scalewhen funded

When capital does flow, women-led healthcare startups can build major platforms. A widely covered example is Maven Clinic, a women-focused digital
health company that reached a multibillion-dollar valuation following large funding rounds. The point is not that one company “solves” equity, but that
the market repeatedly proves the same lesson: women founders can build category leaders when they’re resourced to compete.

What actually helps: solutions that don’t rely on “just be more confident”

For medical schools and health systems: make advancement measurable and fair

• Clarify promotion and leadership criteria. If “leadership potential” is defined only by informal sponsorship, you’ll keep selecting
  the people who already look like leaders in your institution’s mental picture.
• Track the hidden workload. Measure committee assignments, mentoring hours, and service rolesand reward them appropriately. If the
  “glue work” is essential, it should also be promotable.
• Build sponsorship, not only mentorship. Mentors advise; sponsors advocate when opportunities and titles are on the line.
• Design flexibility into leadership roles. Leadership should not require an “always on” lifestyle to be considered legitimate.
• Audit pay and fix inequities. Transparent compensation frameworks reduce the chance that bias silently compounds over decades.
• Invest in culture and accountability. Strong anti-harassment systems and a healthy climate protect retentionthe raw material of
  leadership.

For investors and accelerators: standardize decisions and widen networks

• Use consistent diligence questions. Research has shown that founders can receive different types of questions based on gender
  (risk-focused vs. growth-focused). Standardizing questions reduces bias and improves comparability.
• Increase women decision-makers. More women in Partner+ roles correlates with more inclusive sourcing, pattern recognition, and
  willingness to back non-traditional markets.
• Fund the full journey, not just the first check. Many gaps show up at later stages (Series B and beyond), where networks and
  “proven founder” bias become stronger.
• Support alternative capital paths. Revenue-based financing, grants, strategic partnerships, and programs that help women entrepreneurs
  access procurement and contracting can reduce dependence on a single gatekeeping system.

For policy and the innovation ecosystem: treat women entrepreneurs as an economic engine

Women-owned businesses already represent a major share of U.S. entrepreneurship and employment. Federal and state programs that expand access to
capital, training, contracting, and mentorship can help close gaps in business survival and scale. The key is not just helping women start companies,
but helping them grow companies.

What individuals can dowithout pretending the system is perfectly fair

System change is essential, but individuals still have careers to build in the meantime. The goal is not to “fix yourself,” but to navigate wisely in a
system that can be inconsistent.

Build a sponsor network (a “sponsor stack”)

Aim for multiple sponsors across domains: one in your specialty, one in hospital operations, one in research/academia, and one outside your institution.
Sponsors help you get on the list before the list is finalizedbecause by the time opportunities are public, the decision may already be half-made.

Document impact in leadership language

Many clinicians do high-impact work but describe it in humble, clinical terms. Translate outcomes into leadership metrics: reduced readmissions,
improved quality scores, lower turnover, increased access, higher patient satisfaction, faster time-to-treatment. Make it easy for decision-makers to
see your work as “organizational value,” not just “being helpful.”

For clinician-founders: design your pitch to survive bias

In healthcare entrepreneurship, you’re pitching to investors, but also to regulators, health systems, and payers. Prepare for mismatched expectations:
you may be asked to prove credibility, market size, and risk mitigation more aggressively than peers. Counter it with tight evidence:
clinical validation, pilot outcomes, clear reimbursement logic, and a plan that’s realistic about adoption.

Why this matters: better leadership creates better healthcare

Gender equity in leadership isn’t a feel-good side quest. It shapes what healthcare prioritizes. Diverse leadership can influence how institutions
address workforce burnout, patient communication, safety culture, and innovation strategy. It affects which health problems get researched, which
technologies get built, and how trustworthy the system feels to the people it serves.

The goal is not “more women leaders” as a symbolic victory. The goal is a healthcare system that uses its full talent pool, makes smarter decisions,
and invests in innovation that reflects real lives. Anything less is like insisting on treating patients with half the formulary because “that’s how we’ve
always done it.”

Experiences people commonly describe in medical leadership and entrepreneurship

Data can show patterns, but day-to-day experiences explain how those patterns form. The stories below are compositesbuilt from themes repeatedly
reported by women clinicians, researchers, and foundersso they illustrate common realities without pointing to any one individual.

1) The “Are you the nurse?” momentrebranded as a leadership problem

A woman physician steps into a patient room with a male trainee. The patient makes eye contact with the trainee and asks him the plan. The physician
gently redirects: “I’m your attending; I’ll walk you through it.” The patient apologizes, but the moment lingers. It’s not only awkwardit’s a preview
of what can happen in meetings, too. When authority is assumed to look a certain way, women leaders often spend extra energy re-establishing their
role before they can even do the work. Over time, that “small” friction becomes a real tax on confidence, time, and perceived legitimacy.

2) The service spiral: indispensable, applauded, and quietly stalled

Another common experience is being praised for reliabilityand then being loaded with tasks that keep the system running but don’t move a career
forward. A faculty member becomes the go-to person for resident support, onboarding, patient communication training, and committee triage. Her work is
valued socially (“We’d be lost without you!”) but not structurally (few protected hours, limited credit in promotion files, and minimal sponsorship for
higher roles). Meanwhile, a colleague with fewer service responsibilities publishes more, travels more, networks more, and becomes the “obvious” chair
candidate. The faculty member isn’t lacking ambition; she’s drowning in organizational needs that are treated like volunteer work.

3) The double bind: decisive equals “abrasive,” collaborative equals “not leaderly”

Women leaders often describe a narrow band of “acceptable” behavior. If they’re direct, they can be labeled difficult. If they’re diplomatic, they can
be labeled unsure. If they advocate for resources, they can be seen as self-interested. If they don’t, they can be overlooked. This double bind shows
up in feedback like: “Great clinician, but…” or “Strong communicator, but not executive presence.” The language is vague, which makes it hard to
contest and easy to repeat. Over time, vague feedback becomes a gatekeeping tool: a reason to delay promotion without ever naming a fixable gap.

4) The pitch meeting where the questions change

In entrepreneurship, women founders often describe walking into investor meetings with strong tractionpilot results, early revenue, customer demand
and still receiving a different tone of questioning. Instead of “How big can this get?” they get “What could go wrong?” Instead of “How fast can you
scale?” they get “How will you avoid failure?” These aren’t bad questions; risk matters. The issue is the imbalance. When one group is repeatedly
pushed into defensive explanations, they have less time to tell the growth story that actually drives investment decisions. Some founders adapt by
leading with risk mitigation and operational strengththen deliberately shifting to market expansion and upside, so they can answer the “prevention”
questions without sacrificing the “promotion” narrative.

5) The “invisible network” gap

Both in medicine and startups, networks matter. Women describe hearing about leadership roles lateor learning that a shortlist already existed before
any formal process. In entrepreneurship, founders may find that warm introductions (the currency of fundraising) flow more easily through
male-dominated circles, especially in specialized sectors like healthcare IT and biotech. The result is not always overt exclusion; it’s a quieter
disadvantage: fewer at-bats, fewer informal champions, and fewer “someone should meet you” moments. That’s why sponsorshippeople using their
credibility to open doorsshows up again and again as a practical solution.

These experiences don’t mean progress is impossible. They mean progress requires design. If institutions and investors want better outcomes,
they can’t rely on “good intentions” alone. They need systems that recognize hidden work, standardize evaluation, and distribute opportunity on purpose.